A5013079926- Diabetes Management and Research
- Health and Lifestyle Studies
- Diabetes Treatment and Management
- Diabetes Management and Education
- Pancreatic function and diabetes
- Mobile Health and mHealth Applications
- Diabetes and associated disorders
Pontificia Universidad Javeriana
2022-2024
No studies have assessed the efficacy of telemedicine using a platform for recording and adjusting insulin doses in patients with diabetes mellitus type 2 (DM2) transitioning from inpatient to outpatient care. This study aimed assess, population DM2, discharged tertiary referral hospital, whether treatment based on use an mHealth application was associated better glycemic control at 3-month follow-up, than standard care.This open, randomized, controlled clinical trial included adult DM2 who...
Introducción: Los anticuerpos monoclonales dirigidos contra el punto de control inmunológico ó inhibidores del check point (ICP), han mejorado pronóstico algunas neoplasias, sin embargo se reportado eventos adversos inmunológicos, con afectación diferentes órganos endocrinos, dentro ellos, diabetes mellitus inducida por ICP (DM-ICP) siendo infrecuente, prevalencia cercana al 2 %, presentándose como tipo 1 (DM1) empeoramiento Diabetes (DM2). Presentamos 4 casos pacientes previamente normo...
Background: This study investigated the characteristics associated with an increased risk of hypoglycemia, in elderly patients type 1 diabetes mellitus (T1D) using automated insulin delivery (AID) systems. Methods: Cross-sectional observational including >60 years, sensor-augmented pump therapy predictive low-glucose management (SAPT-PLGM), hybrid closed-loop (HCL), and advanced (AHCL), for more than three months. A geriatric assessment was performed, body composition determined to...